We’re reposting this seminar because the depth of knowledge being shared is unmatched—and based on registrations, we’re expecting a lively, insight-rich discussion. Whether you're an investor looking to sharpen your due diligence skills or a founder navigating the complex regulatory landscape, this is the kind of session that brings clarity and confidence. ?? Learn about FDA classifications, IP strategy, legal pitfalls, and what it really takes to bring a medical device to market—from the experts who’ve done it. ?? March 26 | ?? 1:00–3:00 PM ET ?? Virtual - click to access the View Event button below for the registration link Learn from the best. Ask the hard questions. Be ready for what’s next. #MedTech #LifeSciences #AngelInvesting #VentureCapital #RegulatoryStrategy #DueDiligence #Startups #InvestorEducation Howard Lubert Brian E. Cain Barry Etra Kirk Otis Richard Reeves Steve Cohen Mike Dunnam Accorto Regulatory Solutions Todd Wallach Christian Haller
?Understanding Regulatory Readiness: A Key to Smarter Life Sciences Investments. >> Regulatory preparedness can make or break a life sciences investment. Investors, venture professionals, and due diligence teams must understand how FDA pathways, intellectual property, and corporate law intersect to shape market access and valuation. Join us for an expert-led seminar designed to clarify these critical regulatory milestones, helping you assess risk and identify stronger investment opportunities. ?? March 26th 1 - 3 PM Eastern | ??Virtual | ?? Register here: https://lnkd.in/ef_EaG6H . Howard Lubert Brian E. Cain Charles D. Albanese Christian Haller Barry Etra Kirk Otis Richard Reeves
此处无法显示此内容
在领英 APP 中访问此内容等